Molecular Roadblocks for Cellular Reprogramming

Slides:



Advertisements
Similar presentations
1 Lecture 2: Nuclear Reprogramming. Nuclear Reprogramming 2 Switch of gene expression from one cell type to another Switch from a differentiated, specialized.
Advertisements

Outline Molecular Cell Biology Assessment Review from last lecture Role of nucleoporins in transcription Activators and Repressors Epigenetic mechanisms.
Chapter 2. Differential gene expression in Development
Chromatin Control of Developmental Dynamics and Plasticity
Approaching TERRA Firma: Genomic Functions of Telomeric Noncoding RNA
Volume 49, Issue 1, Pages 3-5 (January 2013)
The 3D Genome Shapes Up For Pluripotency
Pluripotent Stem Cells from Cloned Human Embryos: Success at Long Last
Volume 17, Issue 6, Pages (December 2015)
Methed-Up FOXOs Can't In-Akt-ivate
Human Somatic Cell Nuclear Transfer Is Alive and Well
Reprogramming the Methylome: Erasing Memory and Creating Diversity
Jacob H. Hanna, Krishanu Saha, Rudolf Jaenisch  Cell 
Modification of Enhancer Chromatin: What, How, and Why?
Transcriptional Addiction in Cancer
RNA Processing and Genome Stability: Cause and Consequence
Yingqun Huang, Renata Gattoni, James Stévenin, Joan A. Steitz 
Epigenetics Drives RAGs to Recombination Riches
Induced Neuronal Cells: How to Make and Define a Neuron
A rapidly evolving revolution in stem cell biology and medicine
Unraveling Epigenetic Regulation in Embryonic Stem Cells
Rudolf Jaenisch, Richard Young  Cell 
Chromatin Insulators: Linking Genome Organization to Cellular Function
The Hierarchy of the 3D Genome
Mechanisms and Consequences of Alternative Polyadenylation
Control of the Embryonic Stem Cell State
Vanessa Brès, Tomonori Yoshida, Loni Pickle, Katherine A. Jones 
Small Molecules, Big Effects: A Role for Chromatin-Localized Metabolite Biosynthesis in Gene Regulation  Bryan A. Gibson, W. Lee Kraus  Molecular Cell 
Beyond the Sequence: Cellular Organization of Genome Function
Human Promoters Are Intrinsically Directional
Unlinking an lncRNA from Its Associated cis Element
Patrick Trojer, Danny Reinberg  Molecular Cell 
Volume 19, Issue 3, Pages (September 2016)
Volume 49, Issue 1, Pages 1-3 (January 2013)
Cancer Modeling in the Modern Era
Xin Huang, Jianlong Wang  Molecular Cell 
Volume 13, Issue 9, Pages (December 2015)
Mitotic Bookmarking: Maintaining the Stem Cell Identity during Mitosis
Reprogramming the Methylome: Erasing Memory and Creating Diversity
The DUBle Life of Polycomb Complexes
Genome Regulation by Polycomb and Trithorax Proteins
Molecular Basis for Target RNA Recognition and Cleavage by Human RISC
Epigenetic Memory and Preferential Lineage-Specific Differentiation in Induced Pluripotent Stem Cells Derived from Human Pancreatic Islet Beta Cells 
Molecular Mechanisms of Long Noncoding RNAs
Epigenome Maintenance in Response to DNA Damage
“Transflammation”: When Innate Immunity Meets Induced Pluripotency
Long Noncoding RNAs in Cell-Fate Programming and Reprogramming
Functional and Mechanistic Diversity of Distal Transcription Enhancers
A Transcriptional Logic for Nuclear Reprogramming
Epigenetic Transitions in Germ Cell Development and Meiosis
Enhancer Malfunction in Cancer
Pok Kwan Yang, Mitzi I. Kuroda  Cell 
Occupying Chromatin: Polycomb Mechanisms for Getting to Genomic Targets, Stopping Transcriptional Traffic, and Staying Put  Jeffrey A. Simon, Robert E.
A Role for Epigenetics in Psoriasis: Methylated Cytosine–Guanine Sites Differentiate Lesional from Nonlesional Skin and from Normal Skin  Johann E. Gudjonsson,
Transcriptional Regulation and Its Misregulation in Disease
Volume 13, Issue 9, Pages (December 2015)
Polycomb Group Proteins Set the Stage for Early Lineage Commitment
Epigenetics in Alternative Pre-mRNA Splicing
Genetic and Epigenetic Regulators of Pluripotency
Transcriptional Scaffolds for Heterochromatin Assembly
Historical Origins of Transdifferentiation and Reprogramming
Selective Transcription in Response to an Inflammatory Stimulus
Genome-wide “Re”-Modeling of Nucleosome Positions
NuRD and Pluripotency: A Complex Balancing Act
The 3D Genome in Transcriptional Regulation and Pluripotency
Molecular Obstacles to Clinical Translation of iPSCs
Epigenetic factors influencing resistance to nuclear reprogramming
Volume 33, Issue 1, Pages (July 2010)
The Aging Epigenome Molecular Cell
Kevin Huang, Guoping Fan  Cell Stem Cell 
Presentation transcript:

Molecular Roadblocks for Cellular Reprogramming Thomas Vierbuchen, Marius Wernig  Molecular Cell  Volume 47, Issue 6, Pages 827-838 (September 2012) DOI: 10.1016/j.molcel.2012.09.008 Copyright © 2012 Elsevier Inc. Terms and Conditions

Figure 1 Experimental Systems for Studying Nuclear Reprogramming (A) Somatic cell nuclear transfer (SCNT). Nucleus from a donor cell is inserted into an enucleated oocyte. In mammals, the resulting cell can then be cultured in vitro to derive nuclear transfer ESCs (NT-ESCs), which can then be used to generate cloned mice via standard blastocyst injection. Alternatively, blastocysts can be derived from oocytes in vitro (at low efficiency) and implanted into pseudopregnant mice to develop. Measurements of the efficiency of NT-ESC derivation, blastocyst derivation from somatic nuclei, or the generation of live pups can serve as a measure of the efficiency of nuclear reprogramming. (B) Cell fusion. Two distinct cell types are fused together to generate chimeric cells with multiple nuclei. In order to facilitate identification of transcripts or proteins from each fusion partner, cells from different species (e.g., human and mouse) are often used. Fused cells can be purified using fluorescent-activated cell sorting or by double antibiotic selection. In heterokaryons, fused cells maintain distinct nuclei and do not undergo cell division (e.g., Bhutani et al., 2010). Cells can also be selected for stable, dividing clones in which nuclear fusion has occurred. These are referred to as synkaryons or cell hybrids (e.g., Cowan et al., 2005). (C) Transcription factor-mediated reprogramming. Reprogramming transcription factors are introduced into cells via viral vectors, DNA transfection, or RNA transfection. Numerous cell fates can be induced in addition to those shown in the figure (see Figure 2 for a complete list). Strong artificial promoters are generally used to ensure robust expression. Inducible promoters (e.g., tetracycline-inducible) can be used to shut off reprogramming factor expression to determine whether cell fate reprogramming is stable in the absence of exogenous of transcription factor expression. Molecular Cell 2012 47, 827-838DOI: (10.1016/j.molcel.2012.09.008) Copyright © 2012 Elsevier Inc. Terms and Conditions

Figure 2 Transcription Factor-Mediated Conversion of Fibroblasts into Diverse Cellular Lineages Summary of the diverse cell types generated directly from mouse and human fibroblasts by lineage reprogramming. Factors listed in parentheses are required for reprogramming human cells but not for mouse cells. References (starting from the bottom left of the figure and going counterclockwise): Ambasudhan et al., 2011; Caiazzo et al., 2011; Davis et al., 1987; Feng et al., 2008; Huang et al., 2011; Ieda et al., 2010; Kajimura et al., 2009; Lujan et al., 2012; Pang et al., 2011; Pfisterer et al., 2011; Qiang et al., 2011; Sekiya and Suzuki, 2011; Son et al., 2011; Szabo et al., 2010; Takahashi and Yamanaka, 2006; Yoo et al., 2011. Molecular Cell 2012 47, 827-838DOI: (10.1016/j.molcel.2012.09.008) Copyright © 2012 Elsevier Inc. Terms and Conditions

Figure 3 Models of Transcription Factor Binding during the Initiation of Transcriptional Reprogramming (A) Permissive enhancer model (Taberlay et al., 2011). Genes that have promoters that exhibit marks of polycomb-mediated epigenetic silencing (i.e., H3K27me3) can have enhancer elements that exist in a permissive state (i.e., H3K4me1-enriched) and allow for reprogramming factor binding and subsequent chromatin remodeling at the promoter. (B) Pioneer factor model. Reprogramming factors with pioneer activity can bind nucleosomal DNA and can thus access cis-regulatory elements that exist in a chromatin state that is thought to preclude binding of most transcription factors. Pioneer factor binding can displace nucleosomes and recruit chromatin modifying proteins or additional transcription factors, leading to activation of previously “nonpermissive” genes. (C) Spontaneous accessibility. Reprogramming transcription factors bind to cis-regulatory regions during transient unwrapping of nucleosome-bound DNA that would normally be sterically occluded. High levels of reprogramming factor expression could help to increase the likelihood of this occurring at a high enough fraction of important cis-regulatory regions that it is relevant for reprogramming. (D) Accessibility during cell division. Reprogramming transcription factors gain access to occluded cis-regulatory regions during cell division. Copying the genome requires pre-existing nucleosomes to be temporarily displaced and the insertion of initially unmodified histones into newly copied DNA strands. These processes are likely to interrupt the stable epigenetic silencing of these loci and could thus allow reprogramming factors (especially when expressed at high levels) to bind to these temporarily available sites and cause chromatin remodeling, leading to stable transcriptional reprogramming. Molecular Cell 2012 47, 827-838DOI: (10.1016/j.molcel.2012.09.008) Copyright © 2012 Elsevier Inc. Terms and Conditions